Prostate Specific Antigen ELISA Kit

Catalog No. ABIN996897

Product Details Prostate Specific Antigen ELISA Kit

Target: Prostate Specific Antigen (PSA)

Reactivity: Human

Detection Method: Colorimetric

Method Type: Sandwich ELISA

Detection Range: 0-60 ng/mL

Minimum Detection Limit: 0 ng/mL

Application: ELISA

Purpose: The PSA Enzyme Immunoassay test kit is intended for the quantitative determination of PSA in human serum.

Sample Type: Serum

Analytical Method: Quantitative

Specificity: 98.7 %

Sensitivity: 0.5 ng/mL

Application Details

Sample Volume: 25 μL

Assay Time: 1 h

Plate: Pre-coated

Restrictions: For Research Use only

Handling

Storage: 4 °C

Expiry Date: 12 months

Target Details for Prostate Specific Antigen

Target: Prostate Specific Antigen (PSA)

Alternative Name: PSA (PSA Products)

Synonyms: APS ELISA Kit, KLK2A1 ELISA Kit, PSA ELISA Kit, hK3 ELISA Kit, KLK3 ELISA Kit, Klk1c10l2 ELISA Kit, RSGK-50 ELISA Kit, RSKG-50 ELISA Kit, rGK-3 ELISA Kit, Kal-3 ELISA Kit, Kal3 ELISA Kit, Klk3 ELISA Kit, AAP-S ELISA Kit, MP100 ELISA Kit, Psa ELISA Kit, R74825 ELISA Kit, goku ELISA Kit, kallikrein related peptidase 3 ELISA Kit, kallikrein 3 ELISA Kit, kallikrein 1-related peptidase C3 ELISA Kit, kallikrein B, plasma 1 ELISA Kit, aminopeptidase puromycin sensitive ELISA Kit, KLK3 ELISA Kit, Klk1c3 ELISA Kit, Klkb1 ELISA Kit, Npepps ELISA Kit

Background: Human prostate-specific antigen (PSA) is a serine protease, a sigle chain glycoprotein with a molecular weight of approximately 34,000 daltons containing 7% carbohydrate by weight. PSA is immunologically specific for prostatic tissue, it is present in normal, benign hyperplastic, and malllignant prostatic tissue, in metastatic prostatic carcinoma, and also in prostatic fluid and seminal plasma. PSA is not present in any other normal tissue obtained from men, nor is it produced by cancers of the breast, lung, colon, rectum, stomach, pancreas or thyroid. Besides, it is functionally and immunologically different from prostatic acid phosphatase (PAP). Elevated serum PSA concentrations have been reported in patients with prostate cancer, benign prostatic hypertrophy, or inflammatory conditions of other adjacent genitourinary tissues, but not in apparently healthy men, men with non-prostatic carcinoma, apparently healthy women, or women with cancer. Reports have suggested that serum PSA is one of the most useful tumor markers in oncology. It may serves as an accurate marker for assessing response to treatment in patients with prostatic cancer. Therefore, measurement of serum PSA concentrations can be an important tool in monitoring patients with prostatic cancer and in determining the potential and actual effectiveness of surgery or other therapies. Recent studies also indicate that PSA measurements can enhancce early prostate cancer detection when combined with digital rectal examination (DRE).

Pathways: Complement System